Mar Cor Purification Recalls Central Water Platform Reverse Osmosis Systems
Mar Cor Purification is recalling 197 Central Water Platform (CWP) reverse osmosis systems because a specific lot of water inlet solenoid valves may fail, stopping water production.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall. The hazard is a functional failure (cessation of water production) rather than a direct injury or contamination, and no illnesses or injuries are reported in the source text.
Plain-English summary
Mar Cor Purification is recalling 197 units of its Central Water Platform (CWP) reverse osmosis systems, models 102, 104, and 106. These systems are intended to produce water for the dialysis of multiple patients. The recall was initiated due to a potential issue with a specific lot of water inlet solenoid valves.
The hazard is that the water inlet solenoid valve could cease to function. If this occurs, the CWP will stop producing reverse osmosis water. The source text does not report any illnesses, injuries, or deaths associated with this defect.
The affected units were distributed nationwide in the United States, including in Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, and Wisconsin. Users should contact Mar Cor Purification for instructions on how to address the potential valve failure.
The recalled product
- Product
- Mar Cor Purification, Central Water Platform (CWP), 102, 104 and 106. Product Usage: The CWP is a Central reverse osmosis system with the intended use of producing water for dialysis of multiple patients.
- Manufacturer
- Mar Cor Purification
- Hazard
- Affected units
- 197
Distribution
Related recalls
Same manufacturer · Mar Cor Purification
See all →- HighMar Cor Purification Millenium HX Portable Reverse Osmosis System Recalled
FDA (Devices) · 2014-03-26
- SevereMar Cor Purification Reverse Osmosis Systems Recalled for Fire Risk
FDA (Devices) · 2014-03-19
Same hazard · functional failure
See all →- ModerateOlympus DisplayPort Cable Recalled for Video Dropout Risk
FDA (Devices) · 2026-10-07
- HighAccuVu Angiographic Catheter, Omni Flush, Non-Braided Defect Recall
FDA (Devices) · 2026-04-29
- HighBaxter TruSystem 7500 Hybrid software issue disables upper back adjustment
FDA (Devices) · 2025-04-02
- HighSoftware Malfunction Disables Back Control on Baxter TruSystem 7500
FDA (Devices) · 2025-04-02
- SevereCardiac catheters recalled due to polyurethane layer delamination defects
FDA (Devices) · 2024-05-22
Similar recalls
- SevereMar Cor Purification Reverse Osmosis Systems Recalled for Fire Risk
FDA (Devices) · 2014-03-19
- HighMar Cor Purification Millenium HX Portable Reverse Osmosis System Recalled
FDA (Devices) · 2014-03-26
- HighAmeriWater MRO Dialysis Systems Recalled Due to Incorrect Fuse Installation
FDA (Devices) · 2012-09-12
- HighCardiovascular Systems Recalls Orbital Atherectomy System Saline Infusion Pumps
FDA (Devices) · 2017-05-31
- HighCardiovascular Systems Recalls Orbital Atherectomy Saline Infusion Pumps
FDA (Devices) · 2018-09-19
- HighSteris Caviwave Pro Ultrasonic Cleaning System Recalled for Power Failure Risk
FDA (Devices) · 2015-05-06